Catalyst
Monitor further studies on esketamine's effects in different surgical populations and any regulatory changes regarding its use in perioperative settings.
Date
July 4, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.